Singapore, Sept. 12 -- Strides Pharma Science has announced that its step-down, wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has entered into a strategic product development partnership with US-based Kenox Pharmaceuticals Inc., a fast-growing contract development and manufacturing company specialising in Orally Inhaled and Nasal Drug Products (OINDPs).

Under the terms of the agreement, Strides will collaborate with Kenox on the development and filing of multiple nasal spray products for the US market across diverse therapeutic indications. Specific product details remain confidential at this stage.

DrSitaram Velaga, Founder, President and CEO of Kenox Pharmaceuticals Inc., stated"Our strategic partnership with...